Fact CheckerSign in

NCT07660237Completed

Effects of a Transitional Care Program on Depression, Self-Efficacy, and Self-Care in Patients With Heart Failure

Effects of a Transitional Care Program on Depression, Self-Efficacy, and Self-Care in Patients With Heart Failure: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 22 Jun 2026

Brief summary (registry, in English)

This randomized controlled trial aims to evaluate the effects of a structured transitional care program on depression, self-efficacy, and self-care behaviors in patients with heart failure. Outcomes will be assessed before discharge and at 1 and 3 months after discharge.

Status (registry)
Completed
Study type
Interventional
Enrollment
130 (actual)
First submitted
12 Jun 2026
Start date
19 Jul 2023
Primary completion date
18 Jan 2024
Lead sponsor
Chang Gung Memorial Hospital
NCT number
NCT07660237

What you commit to

  • Study type: Interventional
  • Participants enrolled: 130
  • From 19 Jul 2023 to the primary completion date, 18 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients who are unable to be discharged during the current hospitalization. Severe consciousness impairment, cognitive impairment, or severe mental illness affecting study participation.

Other

  • Patients who are illiterate or unable to express themselves verbally. Patients who are bedridden long-term or unable to perform self-care activities. Patients who refuse to participate in the study. Patients who are already enrolled in a case management program.

Who the study is looking for

  • Patients with a diagnosis of heart failure confirmed by a specialist physician. Patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤40%.
  • Age ≥20 years. Clear consciousness and no cognitive impairment. Ability to communicate in Mandarin, Taiwanese, or Hakka. Ability to complete the questionnaire independently or with assistance from the researcher.

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chang Gung Memorial Hospital
Coordinator of this site? Confirm its status
GuishanTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.